This FOA invites applications for investigator-initiated, high-risk multi-center clinical trials involving more than one clinical center.
Proposed trials should be hypothesis-driven, have the potential to change clinical practice and/or public health, and focus on a disease relevant to the mission
credit:
of NIDDK.
Planning activities must be completed prior to submission and are not permitted under this FOA.
Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see TEMP9971).Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.